Skip to main navigation Skip to search Skip to main content

Beyond model interpretability using LDA and decision trees for α-amylase and α-glucosidase inhibitor classification studies

  • Karel Diéguez-Santana
  • , Oscar M. Rivera-Borroto
  • , Amilkar Puris
  • , Hai Pham-The
  • , Huong Le-Thi-Thu
  • , Bakhtiyor Rasulev
  • , Gerardo M. Casañola-Martin

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

In this report are used two data sets involving the main antidiabetic enzyme targets α-amylase and α-glucosidase. The prediction of α-amylase and α-glucosidase inhibitory activity as antidiabetic is carried out using LDA and classification trees (CT). A large data set of 640 compounds for α-amylase and 1546 compounds in the case of α-glucosidase are selected to develop the tree model. In the case of CT-J48 have the better classification model performances for both targets with values above 80%–90% for the training and prediction sets, correspondingly. The best model shows an accuracy higher than 95% for training set; the model was also validated using 10-fold cross-validation procedure and through a test set achieving accuracy values of 85.32% and 86.80%, correspondingly. Additionally, the obtained model is compared with other approaches previously published in the international literature showing better results. Finally, we can say that the present results provided a double-target approach for increasing the estimation of antidiabetic chemicals identification aimed by double-way workflow in virtual screening pipelines.

Original languageEnglish
Pages (from-to)1414-1421
Number of pages8
JournalChemical Biology and Drug Design
Volume94
Issue number1
DOIs
StatePublished - Jul 2019
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2019 John Wiley & Sons A/S

Keywords

  • antidiabetic agents
  • decision trees
  • linear discriminant analysis
  • QSAR

Fingerprint

Dive into the research topics of 'Beyond model interpretability using LDA and decision trees for α-amylase and α-glucosidase inhibitor classification studies'. Together they form a unique fingerprint.

Cite this